Alligator Bioscience: Interview with CEO Søren Bregenholt (video)
Research Interview
2022-09-30
08:00
Redeye interviewed CEO Søren Bregenholt about the IND approval for ALG.APV-527 and the new results from mitazalimab’s phase II trial published at the AACR.
RR
Richard Ramanius
Disclosures and disclaimers